Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metal Panel T.R.U.E. Test Safety and Efficacy Study
NCT04500834Phase 3Unknown
- Sponsor
- Allerderm Laboratories, Inc.
- Start
- Feb 2022
- Primary completion
- Mar 2025
- Countries
- 1
01
Overview
Phase 3, single-arm trial in allergic contact dermatitis (ACD), sponsored by Allerderm Laboratories, Inc. Primary endpoint: Number of participants with positive, negative, irritant or doubtful patch test responses and concordance between hydrogel and petrolatum allergens. Status: unknown.
02
Conditions
allergic contact dermatitis (ACD)
Beyond the preview
Go deeper on NCT04500834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04500834.